| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |